Product containing dexbrompheniramine and pseudoephedrine (medicinal product)
RxNorm 400674
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 400674 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing dexbrompheniramine and pseudoephedrine (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MINPrescribable
Multiple Ingredients (MIN):
Dexbrompheniramine / pseudoephedrine
(Atom ID: 12353992)
PTPrescribable
Designated preferred name (PT):
Dexbrompheniramine- and pseudoephedrine-containing product
(Atom ID: 10801007)
FNPrescribable
Full form of descriptor (FN):
Product containing dexbrompheniramine and pseudoephedrine (medicinal product)
(Atom ID: 9724032)
Patient Education
Brompheniramine
Brompheniramine relieves red, irritated, itchy, watery eyes; sneezing; and runny nose caused by allergies, hay fever, and the common cold. Brompheniramine helps control symptoms, but does not treat the cause of the symptoms or speed recovery. Brompheniramine should not be used to cause sleepiness in children. Brompheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
[Learn More]
* Please review the disclaimer below.